# UNITENSEN
> **NDA009217** · New Drug Application · Sponsor: MEDPOINTE PHARM HLC
## Drug
- **FDA Application Number:** NDA009217
- **Application type:** New Drug Application
- **Brand name:** UNITENSEN
- **Generic name:** Cryptenamine Tannates
- **Active ingredients:** CRYPTENAMINE TANNATES
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MEDPOINTE PHARM HLC
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009217)
---
*AI Analytics · CC0 1.0*